Skip to main content
SpringerLink
Log in
Book cover

Management of Urothelial Carcinoma pp 63–66Cite as

Early Radical Cystectomy

  • Chapter
  • First Online:

  • 539 Accesses

Abstract

Although the treatment of non-muscle invasive bladder cancer (NMIBC) is usually managed in a bladder-preserving manner, sometimes the performance of radical cystectomy cannot be avoided. Delayed cystectomy is related to worse oncological outcome; thus, early cystectomy (after bacillus Calmette-Guérin [BCG] failure) or immediate cystectomy (immediately after the diagnosis of NMIBC) is recommended. The 5-year disease-free survival after radical cystectomy in NMIBC patients is up to 80%. However, careful consideration of the risks and benefits of radical cystectomy is essential, because of the potential risk of complications and negative effects on the patient’s quality of life.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196:1021–9. https://doi.org/10.1016/j.juro.2016.06.049.

    Article  PubMed  Google Scholar 

  2. Mathieu R, Lucca I, Rouprêt M, Briganti A, Shariat SF. The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nat Rev Urol. 2016;13:471–9. https://doi.org/10.1038/nrurol.2016.126.

    Article  CAS  PubMed  Google Scholar 

  3. Kim HS, Kim M, Jeong CW, Kwak C, et al. Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis. Urol Oncol. 2014;32:1191–9. https://doi.org/10.1016/j.urolonc.2014.05.008.

    Article  PubMed  Google Scholar 

  4. Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J. Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol. 2015;33:643–50. https://doi.org/10.1200/JCO.2014.57.6967.

    Article  PubMed  Google Scholar 

  5. Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol. 2008;180:1928–32. https://doi.org/10.1016/j.juro.2008.07.056.

    Article  PubMed  Google Scholar 

  6. Casey RG, Catto JWF, Cheng L, Cookson MS, Herr H, Shariat S, et al. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015;67:876–88. https://doi.org/10.1016/j.eururo.2014.10.040.

    Article  PubMed  Google Scholar 

  7. Sylvester RJ, Van Der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–75. https://doi.org/10.1016/j.eururo.2005.12.031.

    Article  PubMed  Google Scholar 

  8. Palou J, Baniel J, Klotz L, Wood D, Cookson M, Lerner S, et al. Urothelial carcinoma of the prostate. Urology. 2007;69:50–61. https://doi.org/10.1016/j.urology.2006.05.059.

    Article  PubMed  Google Scholar 

  9. Moschini M, Soria F, Susani M, Korn S, Briganti A, Roupret M, et al. Impact of the level of urothelial carcinoma involvement of the prostate on survival after radical cystectomy. Bladder Cancer. 2017;3:161–9. https://doi.org/10.3233/BLC-160086.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Seisen T, Compérat E, Léon P, Roupret M. Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection. Curr Opin Urol. 2014;24:524–31. https://doi.org/10.1097/MOU.0000000000000086.

    Article  PubMed  Google Scholar 

  11. Alvarado-Cabrero I, Sierra-Santiesteban FI, Mantilla-Morales A, Hernández-Hernandez DM. Micropapillary carcinoma of the urothelial tract: a clinicopathologic study of 38 cases. Ann Diagn Pathol. 2005;9:1–5. https://doi.org/10.1053/j.anndiagpath.2004.10.001.

    Article  PubMed  Google Scholar 

  12. Kamat AM, Gee JR, Dinney CPN, Grossman HB, Swanson DA, Millikan RE, et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol. 2006;175:881–5. https://doi.org/10.1016/S0022-5347(05)00423-4.

    Article  PubMed  Google Scholar 

  13. Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol. 2007;178:2302–7. https://doi.org/10.1016/j.juro.2007.08.038.

    Article  PubMed  Google Scholar 

  14. Bansal A, Kumar N, Sharma SC. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. J Cancer Res Ther. 2013;9:571–3. https://doi.org/10.4103/0973-1482.126449.

    Article  PubMed  Google Scholar 

  15. Kaimakliotis HZ, Monn MF, Cheng L, Masterson TA, Cary KC, Pedrosa JA, et al. Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes. Urology. 2014;83:1112–6. https://doi.org/10.1016/j.urology.2013.12.035.

    Article  PubMed  Google Scholar 

  16. Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, Van Andel G, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guérin. Eur Urol. 2016;69:60–9. https://doi.org/10.1016/j.eururo.2015.06.045.

    Article  PubMed  Google Scholar 

  17. Tan WS, Rodney S, Lamb B, Feneley M, Kelly J. Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treat Rev. 2016;47:22–31. https://doi.org/10.1016/j.ctrv.2016.05.002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Seoul National University Hospital, Seoul, South Korea

    Jungyo Suh

Authors
  1. Jungyo Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Seoul National University Hospital, Seoul, Korea (Republic of)

    Ja Hyeon Ku

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suh, J. (2019). Early Radical Cystectomy. In: Ku, J. (eds) Management of Urothelial Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-10-5502-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5502-7_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5501-0

  • Online ISBN: 978-981-10-5502-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation